Brief: China Regenerative Medicine Int'l Enters Into Placing Agreement With SBI And Grand Partners
03/03/2020 24:37
March 3 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* ENTERED INTO PLACING AGREEMENT WITH SBI AND GRAND PARTNERS
* CHINA REGENERATIVE MEDICINE INTERNATIONAL-UNDER DEAL, SBI
&
GRAND PARTNERS TO PROCURE PLACEES TO SUBSCRIBE FOR UP TO 500
MILLION PLACING SHARES AT HK$0.20
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7ScQ90
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital